Amid coronavirus scare, India restricts export of 26 Active Pharmaceutical Ingredients

By ANI | Updated: March 3, 2020 19:34 IST2020-03-03T19:26:34+5:302020-03-03T19:34:02+5:30

Amid coronavirus outbreak, the Directorate General of Foreign Trade (DGFT) has decided to restrict export of 26 Active Pharmaceutical Ingredients (API) in its revised export policy, due to concerns on the shortage of medicine in domestic markets.

Amid coronavirus scare, India restricts export of 26 Active Pharmaceutical Ingredients | Amid coronavirus scare, India restricts export of 26 Active Pharmaceutical Ingredients

Amid coronavirus scare, India restricts export of 26 Active Pharmaceutical Ingredients

New Delhi [India], Mar 3 : Amid coronavirus outbreak, the Directorate General of Foreign Trade (DGFT) has decided to restrict export of 26 Active Pharmaceutical Ingredients (API) in its revised export policy, due to concerns on the shortage of medicine in domestic markets.

Meanwhile, with the spread of the coronavirus triggering risk-off sentiments, global financial markets have been experiencing considerable volatility.

As per the latest update, global deaths due to coronavirus outbreak on Monday rose to 3115. The deadly virus that originated in China's Wuhan late last year continues to spread around the world and has infected more than 90,000 people across 73 countries.

( With inputs from ANI )

Open in app